MedPath

KoreaN Cohort Study for Outcome in Pediatric Patients With Chronic Kidney Disease

Conditions
Chronic Kidney Disease(CKD)
Registration Number
NCT02165878
Lead Sponsor
Seoul National University Hospital
Brief Summary

KNOW-CKD (KoreaN cohort study for Outcome in patients With Chronic Kidney Disease) is a nation-wide, ten-year longitudinal cohort study, launched in 2011. The aim of the study is to assess the characteristics and risk factors of progression and complications of CKD of Korea. Pediatric sub-cohort of KNOW-CKD is planned to enroll 450 children with CKD, stage I to V (pre-dialysis).

Detailed Description

Seven major pediatric nephrology centers of Korea enrolled children younger than 20 years who had CKD. Medical history taking, questionaire assessment of socio-economic status, anthropometric measurement, and clinical assessment using laboratory and imaging tests were done. Outcome is development of LV hypertrophy or hypertension, growth, neuropsychological status, behavioral status, kidney growth, and quality of life.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
458
Inclusion Criteria
  • Age: < 20 yr
  • CKD stage 1 through 5 of KDIGO guideline
  • predialysis
Read More
Exclusion Criteria
  • Dialysis
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
eGFR10 years

eGFR in mL/min/1.73 m2

Secondary Outcome Measures
NameTimeMethod
Metabolic bone disease10 years

Bone Dexametry in z score

Anemia10 years

Anemia in g/dL

Growth10 years

Height in z score

Development of cardiovascular disease10 years

Hypertrophy in g/m2

Health-related quality of life (HRQOL)10 years

PedsQL 4.0 Generic Core Scale Module (Mapi Research Trust, on behalf of Dr James W. Varni, copyright owner of PedsQL™)

Cognitive skills and emotional development10 years

K-WAIS score

Trial Locations

Locations (1)

Seoul National University Hospital

🇰🇷

Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath